Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation

Broad Screening and Identification of Novel Psychoactive Substances in Plasma by High-Performance Liquid Chromatography–High-Resolution Mass Spectrometry and Post-run Library Matching

(2016) Camilla Montesano et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC–MS-MS and Its Identification in a Drug-Related Death

(2016) Donna Papsun et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant

(2016) Madeleine J Swortwood et al.   Bioanalysis

Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MSn, and LC-HR-MS/MS

(2015) Achim T. Caspar et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Metabolic characterization of AH-7921, a synthetic opioid designer drug:in vitrometabolic stability assessment and metabolite identification, evaluation ofin silicoprediction, andin vivoconfirmation

(2015) Ariane Wohlfarth et al.   Drug Testing and Analysis

4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry

(2015) Kayla N. Ellefsen et al.   Forensic Toxicology

Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice

(2015) A. Vigolo et al.   NEUROPHARMACOLOGY

Metabolism of JWH-015, JWH-098, JWH-251, and JWH-307 in silico and in vitro: a pilot study for the detection of unknown synthetic cannabinoids metabolites

(2014) Sabina Strano-Rossi et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC andα-PVT, by human liver microsome

(2014) Takahiro Takayama et al.   BIOMEDICAL CHROMATOGRAPHY

MT-45, a new psychoactive substance associated with hearing loss and unconsciousness

(2014) A. Helander et al.   CLINICAL TOXICOLOGY

Lefetamine-derived designer drugsN-ethyl-1,2-diphenylethylamine (NEDPA) andN-iso-propyl-1,2-diphenylethylamine (NPDPA): Metabolism and detectability in rat urine using GC-MS, LC-MSnand LC-HR-MS/MS

(2014) Carina S. D. Wink et al.   Drug Testing and Analysis

In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography/quadrupole-time-of-flight mass spectrometry

(2013) Elli Tyrkkö et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

New challenges and innovation in forensic toxicology: Focus on the “New Psychoactive Substances”

(2012) Donata Favretto et al.   JOURNAL OF CHROMATOGRAPHY A

In vitro approaches to studying the metabolism of new psychoactive compounds

(2011) Frank T. Peters et al.   Drug Testing and Analysis

A brief history of ‘new psychoactive substances’

(2011) L. A. King et al.   Drug Testing and Analysis